While blood clots are not a documented side effect of Zepbound, patients should be aware of general risk factors for venous thromboembolism that may be present regardless of medication use: Obesity itself (BMI 30 kg/m) Prolonged immobility (long flights, bed rest, sedentary lifestyle) Prior history of DVT or PE Active malignancy or recent surgery Recent hospitalization or major trauma Pregnancy or postpartum period Oral contraceptive or hormone replacement therapy use Inherited or acquired thrombophilia (Factor V Leiden, antiphospholipid syndrome) Smoking Advanced age Warning signs of deep vein thrombosis (DVT) include: Unilateral leg swelling, pain, or tenderness (often in the calf) Warmth and redness over the affected area Heaviness or aching in the leg Warning signs of pulmonary embolism (PE) include: Sudden onset of shortness of breath or difficulty breathing Sharp chest pain that worsens with deep breathing or coughing Rapid heart rate or palpitations Coughing up blood (hemoptysis) Lightheadedness, dizziness, or syncope Anxiety Patients starting Zepbound should maintain adequate hydration, remain physically active as tolerated, and avoid prolonged periods of immobility
We will look at the science of gastric emptying, common side effects, and when to seek professional guidance
GLP1induced release of atrial natriuretic peptide (ANP) and suppression of renal angiotensin II further augment salt excretion, lowering intravascular volume and blood pressure
The relationship between weight loss injections and heart health is complex
These properties make BPC-157 a valuable research compound for studying injury response and repair pathways
As a result, digital health companies such as Hims & Hers have been prescribing compounded semaglutide as an alternative for patients who are navigating volatile supply hurdles and insurance obstacles
